Neo7 Bioscience @neo7bioscience

Today, we celebrate 250 years of American independence—a legacy built on courage, innovation, and the pursuit of a better future. At Neo7 Bioscience, that same spirit inspires our mission every day. We believe the future of healthcare lies in precision molecular solutions that move medicine beyond treating disease and toward predicting, preventing, and intercepting it before it begins. As we honor our nation’s past, we’re committed to helping shape a healthier future through innovation, scientific discovery, and personalized care. Wishing you, your family, and our community a safe and meaningful Independence Day. 🇺🇸 Happy Fourth of July. Beyond Diagnosis. Toward Interception.

Imagine if we treated smoke before the fire. That's the direction precision medicine is moving. Instead of waiting for disease to become visible, we're learning to identify molecular changes while intervention is still possible. Healthcare is shifting from reacting to disease to understanding biology in real time. The question isn't if this transition will happen. It's how quickly we'll embrace it. learn more: neo7bioscience.com #PrecisionMedicine #PrecisionOncology #CancerResearch #Biotechnology #MolecularMedicine #Cancer #Oncology #EarlyDetection #Biomarkers #HealthcareInnovation #Longevity #FutureOfMedicine #SystemsBiology #PersonalizedMedicine #MedicalInnovation

The question isn't whether we need better drugs. The question is whether we need a fundamentally different strategy. Neo7Bioscience believes the future isn't built on suppressing a single pathway. It's built on Precision Signal Interception—mapping each patient's unique tumor biology, identifying the molecular signals driving disease, and continuously adapting therapy as cancer evolves. The era of temporary brakes is ending. The future belongs to intelligent, adaptive, precision medicine. 📖 Read the full Substack article. #PancreaticCancer #PrecisionMedicine #Oncology #CancerResearch #Neo7Bioscience

BeyondBio / John Catanzaro @Docjohnc

a week ago

⁉️Daraxonrasib Hype Vs. Reality⁉️ Neo7Bioscience Personalized Precision Targeting Is The Way To Go! Pancreatic cancer has long been defined by grim statistics and limited options. Even in 2026, the five-year survival rate remains stuck at just 13%. For too long, patients have

2 2 4 457 2

Pancreatic cancer remains one of the deadliest cancers in medicine. At ASCO 2026, Daraxonrasib demonstrated meaningful progress, extending median progression-free survival from 3.6 to 7.2 months compared with chemotherapy. Progress deserves recognition. But so does perspective. Pancreatic cancer is relentlessly adaptive. It evolves, rewires its signaling networks, and develops resistance—often within months. The question isn't whether we need better drugs. The question is whether we need a fundamentally different strategy. Neo7Bioscience believes the future isn't built on suppressing a single pathway. It's built on Precision Signal Interception—mapping each patient's unique tumor biology, identifying the molecular signals driving disease, and continuously adapting therapy as cancer evolves. The era of temporary brakes is ending. The future belongs to intelligent, adaptive, precision medicine. @neo7bioscience @Docjohnc @NicHulscher @P_McCulloughMD @McCulloughFund 📖 Read the full Substack article here: open.substack.com/pub/beyondbio/… #PancreaticCancer #PrecisionMedicine #Oncology #CancerResearch #Neo7Bioscience

COVID "VACCINE" GENETIC MATERIAL INTEGRATES INTO THE HUMAN GENOME AND CREATES NON-HUMAN CHIMERIC DNA Our peer-reviewed study found an mRNA “vaccine” spike gene sequence FUSED into chromosome 19 in a young Stage IV bladder cancer victim following three mRNA shots.

dejanira @dejanirasilveir

a week ago

🚨🚨ESPELUZNANTES DECLARACIONES DEL Dr. Chris Shoemaker: "El cariotipo cromosómico de la personas "vacunadas" contra COVID ha sido modificado genética y permanentemente. Un tercio del peso de cada inyección que recibiste era ácido desoxirribonucleico, que tiene la capacidad de

369 3K 6K 932K 3K

Genomic Integration and Molecular Dysregulation in Aggressive Stage IV Bladder Cancer Following COVID-19 mRNA Vaccination: ijirms.in/index.php/ijir… @neo7bioscience @Docjohnc @P_McCulloughMD @McCulloughFund

Your biology is always listening. Every meal, every night of sleep, every workout, every stressful moment sends signals to your cells. The future of medicine isn't just about treating disease—it's about understanding the biology behind those signals before symptoms appear. Better data. Earlier insight. Smarter decisions. Stronger resilience. #PrecisionMedicine #ResilienceMedicine #Longevity #PreventiveHealth #MolecularMedicine

⁉️Daraxonrasib Hype Vs. Reality⁉️ Neo7Bioscience Personalized Precision Targeting Is The Way To Go! Pancreatic cancer has long been defined by grim statistics and limited options. Even in 2026, the five-year survival rate remains stuck at just 13%. For too long, patients have been offered either highly toxic chemotherapy or newer targeted drugs that provide only temporary relief before resistance takes over. In 2026, Daraxonrasib was heavily promoted at the ASCO convention as a major breakthrough. It was celebrated for nearly doubling survival in previously treated patients with metastatic pancreatic cancer. While the data showed real progress compared to chemotherapy, the reality behind the hype tells a more sobering story. In the Phase 3 RASolute 302 trial, daraxonrasib extended median progression-free survival to 7.2 months (versus 3.6 months with chemotherapy) and median overall survival to 13.2 months (versus 6.7 months). In the RAS G12 population, progression-free survival reached 7.3 months versus 3.5 months. These numbers represent median extensions measured in months. Pancreatic cancer cells mutate rapidly and adapt quickly. Most patients progress after roughly seven months as tumors bypass the RAS blockade. There are no guarantees of benefit beyond these median numbers, and long-term durable control remains rare. The toxicity profile is substantial. Two Detailed Cases Demonstrating the Power of Precision Signal Interception Case 1 Case 1: Ampulla of Vater Adenocarcinoma with COVID Spike-Related Complications. Molecular profiling revealed a complex network of active signals, including NES (nestin) driving plasticity and metastasis, resistant EGFR and KRAS signaling, hyperactive STAT3, MET, AKT1, and others linked to invasion and immune evasion. The platform designed 13 high-confidence personalized peptides, including a second-generation design specifically engineered to overcome EGFR and KRAS resistance. A dedicated Spike Mitigation peptide was incorporated to address spike-related transcriptional dysregulation. The patient came off toxic chemotherapy and transitioned to solo Neo7 personalized peptide therapy. No adverse reactions occurred. Molecular surveillance and imaging showed tumor clearance in key areas, with stability and improvement in previously affected regions. Quality of life improved significantly. The patient remains alive and continues defense through ongoing revision designs focused on intercepting emerging Cancer Stem Cell signals. Case 2 Case 2: Pancreatic Ductal Adenocarcinoma. Signal mapping identified critical drivers, including TUBB, CDH1, MET, DDR2, LYN, and THBS1, that span multiple hallmarks, such as proliferation, invasion, angiogenesis, and immune evasion. Personalized peptides were designed with cell-penetrating and tumor-penetrating motifs to enable precise intracellular signal interception. HLA typing remained consistent across sample types, supporting accurate immune matching. The patient transitioned off chemotherapy to solo Neo7 personalized peptide therapy with no adverse reactions. Tumor clearance was achieved, quality of life improved dramatically, and survival was extended. The patient continues to be under active molecular surveillance, with revised designs ready to intercept new escape signals. In both cases, patients achieved meaningful tumor control and clearance without chemotherapy toxicity and with the ability to adaptively intercept resistance — results that stand in clear contrast to the median-limited profile of single-class suppression. @P_McCulloughMD @NicHulscher @McCulloughFund Read the Substack: open.substack.com/pub/johncatanz…

Most people think longevity is about adding years to life. The future is about adding life to years. The greatest challenge isn't living longer. It's preserving the energy, resilience, cognitive performance, and biological capacity that make those years meaningful. Longevity without vitality isn't enough. full article on substack: open.substack.com/pub/beyondbio/… #Longevity #Healthspan #PrecisionMedicine #Neo7Bioscience

🚨 New on Substack Disease is often the final signal—not the first. Long before diagnosis, biology is already changing. In The Invisible Decline, we explore why resilience may be the most important health metric of the future. The future belongs to those who can see decline before it becomes diagnosis. read the full artcle: open.substack.com/pub/beyondbio/… #Neo7Bioscience #PrecisionMedicine #MolecularIntelligence #Longevity

The most dangerous phase of disease may be the phase nobody sees. Not the diagnosis. Not the symptoms. Not the treatment. The years before any of those occur. Biology begins changing long before disease becomes visible. Cells adapt. Systems compensate. Resilience declines. By the time symptoms appear, the story may already be well underway. The future of healthcare won't be built on reacting faster. It will be built on seeing earlier. Our latest Substack explores why the greatest opportunity in medicine may exist before diagnosis. Link: open.substack.com/pub/beyondbio/… #PrecisionMedicine #MolecularIntelligence #SystemsBiology #Neo7Bioscience

keyboard_arrow_left Previous keyboard_arrow_right Next

What We Have Observed Regarding Spike-Associated Biological Damage While research continues to evolve, a growing body of published literature, ongoing molecular investigations, and observations from active patient datasets have identified recurring patterns of biological disruption associated with persistent spike protein exposure and expression. The evidence increasingly suggests that spike-associated injury is not confined to a single organ system. Rather, it appears capable of affecting multiple interconnected biological networks that govern resilience, repair, immune surveillance, metabolism, and cellular function. In both published findings and active patient data, we have observed recurring patterns that include: •Disruption of normal brain function, neuroinflammatory pathways, and neurovascular integrity. •Injury to the heart, vascular endothelium, and microcirculation. •Lung damage, inflammatory remodeling, fibrosis-related pathways, and impaired respiratory resilience. •Kidney stress and disruption of normal tissue repair mechanisms. •Alterations of the microbiome and weakening of protective microbial ecosystems that support immune defense. •Disease-promoting shifts across multiple biological systems that reduce the body’s ability to maintain resilience and homeostasis. •Mitochondrial dysfunction resulting in diminished cellular energy production, increased oxidative stress, and impaired recovery capacity. •Dysregulation of immune surveillance, reducing the body’s ability to appropriately recognize, respond to, and eliminate biological threats. •Accelerated biological aging characterized by persistent inflammatory and metabolic stress. •Molecular conditions associated with more aggressive cancer behavior, clonal adaptation, progression, and loss of normal cellular regulatory control. Taken together, these observations suggest that spike-associated biological injury should not be viewed merely as an isolated event or transient exposure. Rather, it appears capable of functioning as a systems-level biological disruptor that can influence numerous pathways involved in human health, resilience, recovery, and longevity. At Neo7 Bioscience, our focus has been to move beyond symptom management and toward molecular interrogation of these disruptions. Through advanced transcriptomics, proteomics, molecular surveillance, and personalized peptide engineering, we have worked with individuals seeking to restore resilience pathways, improve biological function, and address the complex downstream consequences associated with spike-related molecular dysregulation. The future of medicine is not simply diagnosing damage after it occurs—it is identifying molecular instability early and engineering precision interventions that restore biological resilience before dysfunction becomes disease. @P_McCulloughMD @NicHulscher @McCulloughFund Further Information: neo7bioscience.com

BeyondBio / John Catanzaro @Docjohnc

3 weeks ago

What is Spike? Sometimes the most important questions in medicine are the ones we’re still afraid to ask. Science advances when curiosity is allowed to go further than consensus. The spike protein has become one of the most discussed biological structures of our time, yet many

2 8 20 3K 8

What is Spike? One of the most discussed biological structures of our time remains one of the most important to understand. Science advances through investigation, not assumption. How does spike interact with inflammation, immune signaling, vascular function, and biological resilience? The answers may help shape the future of healthcare. My latest article explores why understanding biology—not defending narratives—is the foundation of better medicine. Progress begins with better questions. — Dr. John Catanzaro read full article: open.substack.com/pub/beyondbio/… #WhatIsSpike #PrecisionMedicine #MolecularIntelligence #SystemsBiology #HealthcareInnovation #Neo7Bioscience

What is Spike? One of the most discussed biological structures of our time is also one of the least understood. At Neo7, we believe scientific progress begins by asking better questions and following the data wherever it leads. Understanding how spike interacts with inflammation, immune signaling, vascular health, and cellular resilience may be critical to understanding what comes next in healthcare. The future won’t be built on assumptions. It will be built on molecular intelligence. — Dr. John Catanzaro #Neo7Bioscience #WhatIsSpike #PrecisionMedicine #MolecularIntelligence #HealthcareInnovation

For decades, healthcare has focused on identifying disease. But what if the future depends on understanding resilience? Why do some individuals recover faster? Why do some biological systems adapt while others fail? The next frontier in healthcare may not be disease detection alone—it may be measuring, understanding, and strengthening human resilience. Read Episode 4 of the Neo7 June Series: The Biology of Resilience Because the future isn't simply extending lifespan. It's expanding healthspan. full link: open.substack.com/pub/beyondbio/… #Neo7Bioscience #Healthspan #PrecisionMedicine #Longevity #Biotechnology #FutureOfHealthcare

Disease doesn't begin when symptoms appear. That's simply when we notice it. The molecular signals often emerge months—or years—earlier. The next generation of healthcare will not be built around waiting. It will be built around understanding. Understanding biology. Understanding trajectories. Understanding where systems are headed before dysfunction becomes disease. This is the shift from reactive medicine to precision intervention. This is Molecular Precision Utility. This is the future Neo7 is helping build. Beyond Diagnosis. Toward Interception.

keyboard_arrow_left Previous keyboard_arrow_right Next

Most healthcare systems are designed to identify disease after dysfunction becomes visible. But biology begins communicating long before symptoms appear. The future of medicine belongs to those who can detect early, interpret smarter, and intervene with precision before irreversible damage occurs. At Neo7, we're helping architect the transition from: → Static to Dynamic → Reactive to Precision → Disease Focus to Resilience Focus → Risk to Reward Beyond Diagnosis. Toward Interception. Read Episode 3 of our June Series: open.substack.com/pub/beyondbio/… #Neo7 #MolecularIntelligence #PrecisionMedicine #SystemsBiology #HealthcareInnovation #Biotechnology #Longevity #FutureOfHealthcare

keyboard_arrow_left Previous keyboard_arrow_right Next

Biology doesn't fail overnight. Long before symptoms appear, your body is communicating through cellular signaling, immune adaptation, metabolic shifts, mitochondrial function, and protein pathway activity. The future of medicine won't belong to those who react fastest. It will belong to those who understand biological signals earliest. This is the Molecular Intelligence Era. Neo7 is helping build what comes next.

keyboard_arrow_left Previous keyboard_arrow_right Next

Dr. Catanzaro is spot on. Medicine has the power to rise above reactive patterns and build a brighter future by paying attention before any breaking point arrives. Imagine the incredible progress we could unlock by tackling challenges head on today: healthier communities, honest practitioners, and innovative systems that help patients thrive. By heeding this call, we honor the noble heart of medicine and can prove that we are capable of wisdom and strength long before a collapse. The time to act is now, and the potential rewards are extraordinary. @Docjohnc @neo7bioscience

Synthetic messenger RNA vaccines and transcriptomic dysregulation: Evidence from new-onset adverse events and cancers post-vaccination: pmc.ncbi.nlm.nih.gov/articles/PMC12… @Docjohnc @neo7bioscience @McCulloughFund